chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient given monovalent vaccine instead of bivalent as booster dose
Age: 20.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, No adverse event, Product administration error
Clinical narrative: No adverse event reported. I am reporting a vaccine administration error. The minimum interval had not been met between completion of the primary series and the administration of the bivalent booster dose. Last dose of primary series was 1/30/23. The bivalent booster was administered 2/24/23. Contacted Pfizer to report and find out if dose needs to be repeated. Recommendation was to wait 8 weeks after invalid dose and repeat the bivalent booster. Patient will be contacted regarding this information.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient given monovalent vaccine instead of bivalent as booster dose
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Back pain, Blood alcohol increased, Blood pressure increased, Cervical vertebral fracture
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65-year-old male with a past medical history of hypertension and alcohol use disorder who presented to the emergency department as a level 2 trauma after falling down flight of stairs, EtOH level on arrival was 312.  GCS 14 on arrival, initially complained of neck and upper back pain, otherwise he was hemodynamically stable.  CT imaging of head and torso on intake was notable for left parietal fracture, trace acute subdural bleed, left zygomatic arch which fracture, type 2 dens fracture, sternal fracture and multiple bilateral rib fractures, with fractures in ribs 1 through 6 on the left and 1 through 5 on the right, rib 1 being fractured in 2 places.  There was also fracture in his right 5th finger. Also fra with greater than 50% vertebral loss, minimall displaced spinous fractures of T2-T4 and transverse fractures T4-T5. No solid organ injury in the abdomen.   patient was admitted the ICU with Trauma Surgery as primary service.  Neurosurgery, Orthopedics, and Cardiothoracic surgery were consulted for evaluation of his injuries.  Serial head imaging remained stable and his imaging and physical exam findings for his head and spine necessitated no surgical intervention per Neurosurgery.  The patient had no respiratory distress and no lung injury, necessitating no intervention per CT surgery.  For his R small finger fracture, splint was placed and patient is to follow up with Orthopedic Surgery in 2 weeks.  He has repeat imaging CT head and XR C and T-spine scheduled per Neurosurgery without outpatient follow up to be arranged after imaging.  The patient underwent PT/OT which he tolerated well.  He also demonstrated no signs or symptoms of alcohol withdrawal syndrome.    He was transferred to floor status without complication and care was assumed by the General Medicine team. The patient did test positive for COVID on screening, however he remained asymptomatic.  He had elevated blood pressures during his admission, for which lisinopril was increased to 40 mg daily and he was started on metoprolol tartrate 12.5 mg 2 times a day.  His hospitalization was prolonged due to COVID isolation in preparation for SNF, however the patient made the decision to return home over discharging to SNF. He otherwise remained clinically stable and was medically optimized for discharge home with plan to have LHC" PT/OT services arranged.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Coma scale, Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Facial bones fracture, Fall
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65-year-old male with a past medical history of hypertension and alcohol use disorder who presented to the emergency department as a level 2 trauma after falling down flight of stairs, EtOH level on arrival was 312.  GCS 14 on arrival, initially complained of neck and upper back pain, otherwise he was hemodynamically stable.  CT imaging of head and torso on intake was notable for left parietal fracture, trace acute subdural bleed, left zygomatic arch which fracture, type 2 dens fracture, sternal fracture and multiple bilateral rib fractures, with fractures in ribs 1 through 6 on the left and 1 through 5 on the right, rib 1 being fractured in 2 places.  There was also fracture in his right 5th finger. Also fra with greater than 50% vertebral loss, minimall displaced spinous fractures of T2-T4 and transverse fractures T4-T5. No solid organ injury in the abdomen.   patient was admitted the ICU with Trauma Surgery as primary service.  Neurosurgery, Orthopedics, and Cardiothoracic surgery were consulted for evaluation of his injuries.  Serial head imaging remained stable and his imaging and physical exam findings for his head and spine necessitated no surgical intervention per Neurosurgery.  The patient had no respiratory distress and no lung injury, necessitating no intervention per CT surgery.  For his R small finger fracture, splint was placed and patient is to follow up with Orthopedic Surgery in 2 weeks.  He has repeat imaging CT head and XR C and T-spine scheduled per Neurosurgery without outpatient follow up to be arranged after imaging.  The patient underwent PT/OT which he tolerated well.  He also demonstrated no signs or symptoms of alcohol withdrawal syndrome.    He was transferred to floor status without complication and care was assumed by the General Medicine team. The patient did test positive for COVID on screening, however he remained asymptomatic.  He had elevated blood pressures during his admission, for which lisinopril was increased to 40 mg daily and he was started on metoprolol tartrate 12.5 mg 2 times a day.  His hospitalization was prolonged due to COVID isolation in preparation for SNF, however the patient made the decision to return home over discharging to SNF. He otherwise remained clinically stable and was medically optimized for discharge home with plan to have LHC" PT/OT services arranged.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fracture displacement, Hand fracture, Intensive care, Neck pain, Rib fracture
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65-year-old male with a past medical history of hypertension and alcohol use disorder who presented to the emergency department as a level 2 trauma after falling down flight of stairs, EtOH level on arrival was 312.  GCS 14 on arrival, initially complained of neck and upper back pain, otherwise he was hemodynamically stable.  CT imaging of head and torso on intake was notable for left parietal fracture, trace acute subdural bleed, left zygomatic arch which fracture, type 2 dens fracture, sternal fracture and multiple bilateral rib fractures, with fractures in ribs 1 through 6 on the left and 1 through 5 on the right, rib 1 being fractured in 2 places.  There was also fracture in his right 5th finger. Also fra with greater than 50% vertebral loss, minimall displaced spinous fractures of T2-T4 and transverse fractures T4-T5. No solid organ injury in the abdomen.   patient was admitted the ICU with Trauma Surgery as primary service.  Neurosurgery, Orthopedics, and Cardiothoracic surgery were consulted for evaluation of his injuries.  Serial head imaging remained stable and his imaging and physical exam findings for his head and spine necessitated no surgical intervention per Neurosurgery.  The patient had no respiratory distress and no lung injury, necessitating no intervention per CT surgery.  For his R small finger fracture, splint was placed and patient is to follow up with Orthopedic Surgery in 2 weeks.  He has repeat imaging CT head and XR C and T-spine scheduled per Neurosurgery without outpatient follow up to be arranged after imaging.  The patient underwent PT/OT which he tolerated well.  He also demonstrated no signs or symptoms of alcohol withdrawal syndrome.    He was transferred to floor status without complication and care was assumed by the General Medicine team. The patient did test positive for COVID on screening, however he remained asymptomatic.  He had elevated blood pressures during his admission, for which lisinopril was increased to 40 mg daily and he was started on metoprolol tartrate 12.5 mg 2 times a day.  His hospitalization was prolonged due to COVID isolation in preparation for SNF, however the patient made the decision to return home over discharging to SNF. He otherwise remained clinically stable and was medically optimized for discharge home with plan to have LHC" PT/OT services arranged.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Skull fracture, Spinal fracture, Splint application, Sternal fracture
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65-year-old male with a past medical history of hypertension and alcohol use disorder who presented to the emergency department as a level 2 trauma after falling down flight of stairs, EtOH level on arrival was 312.  GCS 14 on arrival, initially complained of neck and upper back pain, otherwise he was hemodynamically stable.  CT imaging of head and torso on intake was notable for left parietal fracture, trace acute subdural bleed, left zygomatic arch which fracture, type 2 dens fracture, sternal fracture and multiple bilateral rib fractures, with fractures in ribs 1 through 6 on the left and 1 through 5 on the right, rib 1 being fractured in 2 places.  There was also fracture in his right 5th finger. Also fra with greater than 50% vertebral loss, minimall displaced spinous fractures of T2-T4 and transverse fractures T4-T5. No solid organ injury in the abdomen.   patient was admitted the ICU with Trauma Surgery as primary service.  Neurosurgery, Orthopedics, and Cardiothoracic surgery were consulted for evaluation of his injuries.  Serial head imaging remained stable and his imaging and physical exam findings for his head and spine necessitated no surgical intervention per Neurosurgery.  The patient had no respiratory distress and no lung injury, necessitating no intervention per CT surgery.  For his R small finger fracture, splint was placed and patient is to follow up with Orthopedic Surgery in 2 weeks.  He has repeat imaging CT head and XR C and T-spine scheduled per Neurosurgery without outpatient follow up to be arranged after imaging.  The patient underwent PT/OT which he tolerated well.  He also demonstrated no signs or symptoms of alcohol withdrawal syndrome.    He was transferred to floor status without complication and care was assumed by the General Medicine team. The patient did test positive for COVID on screening, however he remained asymptomatic.  He had elevated blood pressures during his admission, for which lisinopril was increased to 40 mg daily and he was started on metoprolol tartrate 12.5 mg 2 times a day.  His hospitalization was prolonged due to COVID isolation in preparation for SNF, however the patient made the decision to return home over discharging to SNF. He otherwise remained clinically stable and was medically optimized for discharge home with plan to have LHC" PT/OT services arranged.
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Subdural haemorrhage, Thoracic vertebral fracture
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "65-year-old male with a past medical history of hypertension and alcohol use disorder who presented to the emergency department as a level 2 trauma after falling down flight of stairs, EtOH level on arrival was 312.  GCS 14 on arrival, initially complained of neck and upper back pain, otherwise he was hemodynamically stable.  CT imaging of head and torso on intake was notable for left parietal fracture, trace acute subdural bleed, left zygomatic arch which fracture, type 2 dens fracture, sternal fracture and multiple bilateral rib fractures, with fractures in ribs 1 through 6 on the left and 1 through 5 on the right, rib 1 being fractured in 2 places.  There was also fracture in his right 5th finger. Also fra with greater than 50% vertebral loss, minimall displaced spinous fractures of T2-T4 and transverse fractures T4-T5. No solid organ injury in the abdomen.   patient was admitted the ICU with Trauma Surgery as primary service.  Neurosurgery, Orthopedics, and Cardiothoracic surgery were consulted for evaluation of his injuries.  Serial head imaging remained stable and his imaging and physical exam findings for his head and spine necessitated no surgical intervention per Neurosurgery.  The patient had no respiratory distress and no lung injury, necessitating no intervention per CT surgery.  For his R small finger fracture, splint was placed and patient is to follow up with Orthopedic Surgery in 2 weeks.  He has repeat imaging CT head and XR C and T-spine scheduled per Neurosurgery without outpatient follow up to be arranged after imaging.  The patient underwent PT/OT which he tolerated well.  He also demonstrated no signs or symptoms of alcohol withdrawal syndrome.    He was transferred to floor status without complication and care was assumed by the General Medicine team. The patient did test positive for COVID on screening, however he remained asymptomatic.  He had elevated blood pressures during his admission, for which lisinopril was increased to 40 mg daily and he was started on metoprolol tartrate 12.5 mg 2 times a day.  His hospitalization was prolonged due to COVID isolation in preparation for SNF, however the patient made the decision to return home over discharging to SNF. He otherwise remained clinically stable and was medically optimized for discharge home with plan to have LHC" PT/OT services arranged.
Age: 96.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Malaise, SARS-CoV-2 test positive
Clinical narrative: Pt is a long-term resident at nursing home. She came to the hospital due to feeling unwell and has atrial fibrillation. She was found to be COVID positive on both antigen and PCR testing, but denies symptoms.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 3 boosters
Age: 36.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Covid vaccine was not viable due to improper temperature storage.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Confusional state, Dyspnoea, Fatigue
Clinical narrative: Immediate sore arm, expected. Then tiredness, also expected. But by ~10-12 hours later, reactions included intensive shivering, (possible) fever, difficulty breathing, confusion, weakness, and an elevated heart rate. Very intense reaction for 5-6 hours, and then something shifted.  I did *not* have hives or swelling.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Heart rate increased, Immediate post-injection reaction, Mobility decreased, Pain in extremity
Clinical narrative: Immediate sore arm, expected. Then tiredness, also expected. But by ~10-12 hours later, reactions included intensive shivering, (possible) fever, difficulty breathing, confusion, weakness, and an elevated heart rate. Very intense reaction for 5-6 hours, and then something shifted.  I did *not* have hives or swelling.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Patient is 9 years old, came in for second dose of moderna Vaccine. Patient was administered a dose of moderna vaccine for 6 months to 5 years of age instead 0.50 mL administered to the left arm. Monitored patient for 15 minutes and no adverse effects.  Second dose of Moderna vaccine administered today. The vaccine bottle was in a bag labeled for 6-11 year old. I looked at the vaccine bottle and it was labeled. 6m-5 years. I went to my charge nurse and informed her that this patient is 9 years old and I took this vaccine bottle out of a the 6-11 year old moderna monovalent bag however it shows 6 month to 5 years. I was informed by my charge nurse that it was the right vaccine to give even though it was labeled 6 months to 5 years. When I sat down to chart unable to find lot number and charge nurse confirmed that I was correct and it was the wrong vaccine for the age group. I called parent and informed her that her daughter received a weaker dose that was suppose to be given for 6 months to 5 years and that there won't be any side effects to be concern of but she will need to come back for another dose in about 1-2 months to receive the correct vaccine for her age. Parent understands.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Wrong product administered
Clinical narrative: Inadvertent/accidental administration of diluent only.   Patient contacted to schedule re-vaccination.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acidosis, Acute respiratory failure, Anticoagulant therapy, Apnoea, Blood gases abnormal
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "52-year-old female with a past medical history of ESRD on HD, hydronephrosis with urostomy in place, and schizophrenia who presented to the emergency department with dyspnea and chest pain, symptom onset 1/19, tested positive for COVID 1/20.  CXR showed central interstitial prominence. EKG showed no ST or T-wave ischemic morphologies, troponin was elevated at 326, no clear established baseline in the setting of ESRD, delta was negative.  Cardiology was consulted and patient was started on a heparin drip given concern for NSTEMI.  Echo was obtained which showed EF 70-75%, small posterior pericardial effusion, otherwise unremarkable.  Given these findings and her symptoms, there was low suspicion for ACS, and heparin gtt was discontinued.  Suspect her presenting symptoms were attributable to COVID pneumonia.  During her hospitalization, the patient developed acute encephalopathy, with reported apneic episodes overnight her nursing. STAT ABG was obtained which showed acidosis with acute hypercapnic respiratory failure. The patient was subsequently put on BiPAP and she underwent urgent dialysis with Nephrology consultation. After these measures, the patient had resolution of her acute metabolic encephalopathy and hypercapnic respiratory failure with return to baseline mentation and maintained stable respiratory status and was weaned back to room air.  She was started on 5 day course of Decadron 6 mg daily to treat COVID, she will complete her course on discharge.  Given her apnea and hypercapnic respiratory failure, there was concern for underlying lung disease, for which referral for sleep study was placed and PFT was ordered.  Patient was evaluated for and recommended home therapies, for which RN/PT/OT home services were arranged. She was discharged in stable condition.  "
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chest pain, Dialysis
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "52-year-old female with a past medical history of ESRD on HD, hydronephrosis with urostomy in place, and schizophrenia who presented to the emergency department with dyspnea and chest pain, symptom onset 1/19, tested positive for COVID 1/20.  CXR showed central interstitial prominence. EKG showed no ST or T-wave ischemic morphologies, troponin was elevated at 326, no clear established baseline in the setting of ESRD, delta was negative.  Cardiology was consulted and patient was started on a heparin drip given concern for NSTEMI.  Echo was obtained which showed EF 70-75%, small posterior pericardial effusion, otherwise unremarkable.  Given these findings and her symptoms, there was low suspicion for ACS, and heparin gtt was discontinued.  Suspect her presenting symptoms were attributable to COVID pneumonia.  During her hospitalization, the patient developed acute encephalopathy, with reported apneic episodes overnight her nursing. STAT ABG was obtained which showed acidosis with acute hypercapnic respiratory failure. The patient was subsequently put on BiPAP and she underwent urgent dialysis with Nephrology consultation. After these measures, the patient had resolution of her acute metabolic encephalopathy and hypercapnic respiratory failure with return to baseline mentation and maintained stable respiratory status and was weaned back to room air.  She was started on 5 day course of Decadron 6 mg daily to treat COVID, she will complete her course on discharge.  Given her apnea and hypercapnic respiratory failure, there was concern for underlying lung disease, for which referral for sleep study was placed and PFT was ordered.  Patient was evaluated for and recommended home therapies, for which RN/PT/OT home services were arranged. She was discharged in stable condition.  "
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction normal, Electrocardiogram normal, Encephalopathy
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "52-year-old female with a past medical history of ESRD on HD, hydronephrosis with urostomy in place, and schizophrenia who presented to the emergency department with dyspnea and chest pain, symptom onset 1/19, tested positive for COVID 1/20.  CXR showed central interstitial prominence. EKG showed no ST or T-wave ischemic morphologies, troponin was elevated at 326, no clear established baseline in the setting of ESRD, delta was negative.  Cardiology was consulted and patient was started on a heparin drip given concern for NSTEMI.  Echo was obtained which showed EF 70-75%, small posterior pericardial effusion, otherwise unremarkable.  Given these findings and her symptoms, there was low suspicion for ACS, and heparin gtt was discontinued.  Suspect her presenting symptoms were attributable to COVID pneumonia.  During her hospitalization, the patient developed acute encephalopathy, with reported apneic episodes overnight her nursing. STAT ABG was obtained which showed acidosis with acute hypercapnic respiratory failure. The patient was subsequently put on BiPAP and she underwent urgent dialysis with Nephrology consultation. After these measures, the patient had resolution of her acute metabolic encephalopathy and hypercapnic respiratory failure with return to baseline mentation and maintained stable respiratory status and was weaned back to room air.  She was started on 5 day course of Decadron 6 mg daily to treat COVID, she will complete her course on discharge.  Given her apnea and hypercapnic respiratory failure, there was concern for underlying lung disease, for which referral for sleep study was placed and PFT was ordered.  Patient was evaluated for and recommended home therapies, for which RN/PT/OT home services were arranged. She was discharged in stable condition.  "
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Interstitial lung disease, Mental status changes, Metabolic encephalopathy, Pericardial effusion, Positive airway pressure therapy
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "52-year-old female with a past medical history of ESRD on HD, hydronephrosis with urostomy in place, and schizophrenia who presented to the emergency department with dyspnea and chest pain, symptom onset 1/19, tested positive for COVID 1/20.  CXR showed central interstitial prominence. EKG showed no ST or T-wave ischemic morphologies, troponin was elevated at 326, no clear established baseline in the setting of ESRD, delta was negative.  Cardiology was consulted and patient was started on a heparin drip given concern for NSTEMI.  Echo was obtained which showed EF 70-75%, small posterior pericardial effusion, otherwise unremarkable.  Given these findings and her symptoms, there was low suspicion for ACS, and heparin gtt was discontinued.  Suspect her presenting symptoms were attributable to COVID pneumonia.  During her hospitalization, the patient developed acute encephalopathy, with reported apneic episodes overnight her nursing. STAT ABG was obtained which showed acidosis with acute hypercapnic respiratory failure. The patient was subsequently put on BiPAP and she underwent urgent dialysis with Nephrology consultation. After these measures, the patient had resolution of her acute metabolic encephalopathy and hypercapnic respiratory failure with return to baseline mentation and maintained stable respiratory status and was weaned back to room air.  She was started on 5 day course of Decadron 6 mg daily to treat COVID, she will complete her course on discharge.  Given her apnea and hypercapnic respiratory failure, there was concern for underlying lung disease, for which referral for sleep study was placed and PFT was ordered.  Patient was evaluated for and recommended home therapies, for which RN/PT/OT home services were arranged. She was discharged in stable condition.  "
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "52-year-old female with a past medical history of ESRD on HD, hydronephrosis with urostomy in place, and schizophrenia who presented to the emergency department with dyspnea and chest pain, symptom onset 1/19, tested positive for COVID 1/20.  CXR showed central interstitial prominence. EKG showed no ST or T-wave ischemic morphologies, troponin was elevated at 326, no clear established baseline in the setting of ESRD, delta was negative.  Cardiology was consulted and patient was started on a heparin drip given concern for NSTEMI.  Echo was obtained which showed EF 70-75%, small posterior pericardial effusion, otherwise unremarkable.  Given these findings and her symptoms, there was low suspicion for ACS, and heparin gtt was discontinued.  Suspect her presenting symptoms were attributable to COVID pneumonia.  During her hospitalization, the patient developed acute encephalopathy, with reported apneic episodes overnight her nursing. STAT ABG was obtained which showed acidosis with acute hypercapnic respiratory failure. The patient was subsequently put on BiPAP and she underwent urgent dialysis with Nephrology consultation. After these measures, the patient had resolution of her acute metabolic encephalopathy and hypercapnic respiratory failure with return to baseline mentation and maintained stable respiratory status and was weaned back to room air.  She was started on 5 day course of Decadron 6 mg daily to treat COVID, she will complete her course on discharge.  Given her apnea and hypercapnic respiratory failure, there was concern for underlying lung disease, for which referral for sleep study was placed and PFT was ordered.  Patient was evaluated for and recommended home therapies, for which RN/PT/OT home services were arranged. She was discharged in stable condition.  "
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Anti-JC virus antibody index, Asthenia, Balance disorder, Computerised tomogram, Confusional state
Clinical narrative: October  2018  1 flu vaccine  :  Seqires, FLUAD., 0.5 ml, 70461-001803 (NDC)        4         internist ? visit for hoarseness                   ENT,? endoscopic exam, all structures normal       During the month ?               Voice ? lower pitch, hoarse, less strength               Hand/ eye ? vision reduced, sometimes double, blurry               Gait ? less coordinated, balance off               Writing ? harder, rougher, not sequenced correctly               Eating ? swallow okay, hard to get food from plate to mouth               Mentation -  confusion regarding dates, emotional changes  Still driving and working Worsening during the month My secretary repeatedly told my husband something was wrong.   November       1,2 ? veering in car, awkward turns 2 -  planning trip for boat trip  3     Cancellled, not safe on roadways            12 ?neurologist ? first MRI    10/1/2018  vaccination date   10/4/2018  3 pm visit for hoarseness 10/18/2018 appt  unrelated to this issue 11/12/2018  MRI and an appointment with Dr 11/13/2018  Dr at hospital 11/27/2018  Admitted 11/27/2018 ? 12/07/2018 11/27/2018  ECG Dr (ER Doctor) 11/28/2019  ECG Dr 12/4/2018  MRI under anesthesia 12/7/2018 ? 12/24/2018  Rehab hospital 1/8/2019  MRI Dr outpatient 11/2019   1/2019  clinic spinal tap 1/2019 Dr 2/12/2019  clinic  MRI Dr 5/29/2019  clinic MRI 10/30/2019  Dr local Neurologist 12/12/2019  Dr integrative MD 1/24/2020  Dr follow up 2/25/2020  Dr Virus antibody 3.56 6/30/2020   - telemedicine 9/4/2020   fx R femur 8/15/2021  fx L femue 8/5/2022  vocal polyp sx
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Coordination abnormal, Diplopia, Dysgraphia, Dysphonia, Electrocardiogram
Clinical narrative: October  2018  1 flu vaccine  :  Seqires, FLUAD., 0.5 ml, 70461-001803 (NDC)        4         internist ? visit for hoarseness                   ENT,? endoscopic exam, all structures normal       During the month ?               Voice ? lower pitch, hoarse, less strength               Hand/ eye ? vision reduced, sometimes double, blurry               Gait ? less coordinated, balance off               Writing ? harder, rougher, not sequenced correctly               Eating ? swallow okay, hard to get food from plate to mouth               Mentation -  confusion regarding dates, emotional changes  Still driving and working Worsening during the month My secretary repeatedly told my husband something was wrong.   November       1,2 ? veering in car, awkward turns 2 -  planning trip for boat trip  3     Cancellled, not safe on roadways            12 ?neurologist ? first MRI    10/1/2018  vaccination date   10/4/2018  3 pm visit for hoarseness 10/18/2018 appt  unrelated to this issue 11/12/2018  MRI and an appointment with Dr 11/13/2018  Dr at hospital 11/27/2018  Admitted 11/27/2018 ? 12/07/2018 11/27/2018  ECG Dr (ER Doctor) 11/28/2019  ECG Dr 12/4/2018  MRI under anesthesia 12/7/2018 ? 12/24/2018  Rehab hospital 1/8/2019  MRI Dr outpatient 11/2019   1/2019  clinic spinal tap 1/2019 Dr 2/12/2019  clinic  MRI Dr 5/29/2019  clinic MRI 10/30/2019  Dr local Neurologist 12/12/2019  Dr integrative MD 1/24/2020  Dr follow up 2/25/2020  Dr Virus antibody 3.56 6/30/2020   - telemedicine 9/4/2020   fx R femur 8/15/2021  fx L femue 8/5/2022  vocal polyp sx
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Emotional disorder, Endoscopy normal, Femur fracture, Gait disturbance, Immunology test
Clinical narrative: October  2018  1 flu vaccine  :  Seqires, FLUAD., 0.5 ml, 70461-001803 (NDC)        4         internist ? visit for hoarseness                   ENT,? endoscopic exam, all structures normal       During the month ?               Voice ? lower pitch, hoarse, less strength               Hand/ eye ? vision reduced, sometimes double, blurry               Gait ? less coordinated, balance off               Writing ? harder, rougher, not sequenced correctly               Eating ? swallow okay, hard to get food from plate to mouth               Mentation -  confusion regarding dates, emotional changes  Still driving and working Worsening during the month My secretary repeatedly told my husband something was wrong.   November       1,2 ? veering in car, awkward turns 2 -  planning trip for boat trip  3     Cancellled, not safe on roadways            12 ?neurologist ? first MRI    10/1/2018  vaccination date   10/4/2018  3 pm visit for hoarseness 10/18/2018 appt  unrelated to this issue 11/12/2018  MRI and an appointment with Dr 11/13/2018  Dr at hospital 11/27/2018  Admitted 11/27/2018 ? 12/07/2018 11/27/2018  ECG Dr (ER Doctor) 11/28/2019  ECG Dr 12/4/2018  MRI under anesthesia 12/7/2018 ? 12/24/2018  Rehab hospital 1/8/2019  MRI Dr outpatient 11/2019   1/2019  clinic spinal tap 1/2019 Dr 2/12/2019  clinic  MRI Dr 5/29/2019  clinic MRI 10/30/2019  Dr local Neurologist 12/12/2019  Dr integrative MD 1/24/2020  Dr follow up 2/25/2020  Dr Virus antibody 3.56 6/30/2020   - telemedicine 9/4/2020   fx R femur 8/15/2021  fx L femue 8/5/2022  vocal polyp sx
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Impaired driving ability, Impaired work ability, Loss of personal independence in daily activities, Lumbar puncture, Magnetic resonance imaging
Clinical narrative: October  2018  1 flu vaccine  :  Seqires, FLUAD., 0.5 ml, 70461-001803 (NDC)        4         internist ? visit for hoarseness                   ENT,? endoscopic exam, all structures normal       During the month ?               Voice ? lower pitch, hoarse, less strength               Hand/ eye ? vision reduced, sometimes double, blurry               Gait ? less coordinated, balance off               Writing ? harder, rougher, not sequenced correctly               Eating ? swallow okay, hard to get food from plate to mouth               Mentation -  confusion regarding dates, emotional changes  Still driving and working Worsening during the month My secretary repeatedly told my husband something was wrong.   November       1,2 ? veering in car, awkward turns 2 -  planning trip for boat trip  3     Cancellled, not safe on roadways            12 ?neurologist ? first MRI    10/1/2018  vaccination date   10/4/2018  3 pm visit for hoarseness 10/18/2018 appt  unrelated to this issue 11/12/2018  MRI and an appointment with Dr 11/13/2018  Dr at hospital 11/27/2018  Admitted 11/27/2018 ? 12/07/2018 11/27/2018  ECG Dr (ER Doctor) 11/28/2019  ECG Dr 12/4/2018  MRI under anesthesia 12/7/2018 ? 12/24/2018  Rehab hospital 1/8/2019  MRI Dr outpatient 11/2019   1/2019  clinic spinal tap 1/2019 Dr 2/12/2019  clinic  MRI Dr 5/29/2019  clinic MRI 10/30/2019  Dr local Neurologist 12/12/2019  Dr integrative MD 1/24/2020  Dr follow up 2/25/2020  Dr Virus antibody 3.56 6/30/2020   - telemedicine 9/4/2020   fx R femur 8/15/2021  fx L femue 8/5/2022  vocal polyp sx
Age: 74.0
Sex: F
Vaccine: FLUA4
Symptoms: Vision blurred, Visual impairment, Vocal cord polyp
Clinical narrative: October  2018  1 flu vaccine  :  Seqires, FLUAD., 0.5 ml, 70461-001803 (NDC)        4         internist ? visit for hoarseness                   ENT,? endoscopic exam, all structures normal       During the month ?               Voice ? lower pitch, hoarse, less strength               Hand/ eye ? vision reduced, sometimes double, blurry               Gait ? less coordinated, balance off               Writing ? harder, rougher, not sequenced correctly               Eating ? swallow okay, hard to get food from plate to mouth               Mentation -  confusion regarding dates, emotional changes  Still driving and working Worsening during the month My secretary repeatedly told my husband something was wrong.   November       1,2 ? veering in car, awkward turns 2 -  planning trip for boat trip  3     Cancellled, not safe on roadways            12 ?neurologist ? first MRI    10/1/2018  vaccination date   10/4/2018  3 pm visit for hoarseness 10/18/2018 appt  unrelated to this issue 11/12/2018  MRI and an appointment with Dr 11/13/2018  Dr at hospital 11/27/2018  Admitted 11/27/2018 ? 12/07/2018 11/27/2018  ECG Dr (ER Doctor) 11/28/2019  ECG Dr 12/4/2018  MRI under anesthesia 12/7/2018 ? 12/24/2018  Rehab hospital 1/8/2019  MRI Dr outpatient 11/2019   1/2019  clinic spinal tap 1/2019 Dr 2/12/2019  clinic  MRI Dr 5/29/2019  clinic MRI 10/30/2019  Dr local Neurologist 12/12/2019  Dr integrative MD 1/24/2020  Dr follow up 2/25/2020  Dr Virus antibody 3.56 6/30/2020   - telemedicine 9/4/2020   fx R femur 8/15/2021  fx L femue 8/5/2022  vocal polyp sx
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Respiratory tract congestion, Tinnitus
Clinical narrative: Feeling of congestion & ringing in ears, progressively got worse, thought it would go away, it didn't.  Worse in left ear.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Asthenia, Back pain, Blood creatine phosphokinase, COVID-19
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "79-year-old male with a past medical history significant for coronary artery disease, CVA with residual left-sided weakness, CKD stage 3 who presented with 1 week of generalized malaise, weakness and falls.  Patient was diagnosed with COVID-19 infection and frequent falls.  On admission patient was also found to have rhabdomyolysis with acute hypoxic respiratory failure at most requiring 3 L of nasal cannula.  During the hospital course, 3 L of nasal cannula was weaned down to room air, patient no longer exhibited signs of acute hypoxic respiratory failure.  Patient was treated with IV rehydration and CPK trended down as well.  Statin was held during this time and will defer to PCP for restarting.  Of note with frequent falls, patient did have significant back pain limiting physical therapy occupational therapy until pain was controlled.  He was found to have a T12 compression fracture, patient was evaluated for inpatient rehab and was accepted, however it was noted that the patient will minimize pain if not prompted prior to therapy sessions.  Patient was discharged with Tylenol and Percocet for pain control prior to working with therapies.  Patient was stable for discharge on the morning of transfer."
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Fall, Malaise, Rhabdomyolysis, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "79-year-old male with a past medical history significant for coronary artery disease, CVA with residual left-sided weakness, CKD stage 3 who presented with 1 week of generalized malaise, weakness and falls.  Patient was diagnosed with COVID-19 infection and frequent falls.  On admission patient was also found to have rhabdomyolysis with acute hypoxic respiratory failure at most requiring 3 L of nasal cannula.  During the hospital course, 3 L of nasal cannula was weaned down to room air, patient no longer exhibited signs of acute hypoxic respiratory failure.  Patient was treated with IV rehydration and CPK trended down as well.  Statin was held during this time and will defer to PCP for restarting.  Of note with frequent falls, patient did have significant back pain limiting physical therapy occupational therapy until pain was controlled.  He was found to have a T12 compression fracture, patient was evaluated for inpatient rehab and was accepted, however it was noted that the patient will minimize pain if not prompted prior to therapy sessions.  Patient was discharged with Tylenol and Percocet for pain control prior to working with therapies.  Patient was stable for discharge on the morning of transfer."
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spinal compression fracture
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "79-year-old male with a past medical history significant for coronary artery disease, CVA with residual left-sided weakness, CKD stage 3 who presented with 1 week of generalized malaise, weakness and falls.  Patient was diagnosed with COVID-19 infection and frequent falls.  On admission patient was also found to have rhabdomyolysis with acute hypoxic respiratory failure at most requiring 3 L of nasal cannula.  During the hospital course, 3 L of nasal cannula was weaned down to room air, patient no longer exhibited signs of acute hypoxic respiratory failure.  Patient was treated with IV rehydration and CPK trended down as well.  Statin was held during this time and will defer to PCP for restarting.  Of note with frequent falls, patient did have significant back pain limiting physical therapy occupational therapy until pain was controlled.  He was found to have a T12 compression fracture, patient was evaluated for inpatient rehab and was accepted, however it was noted that the patient will minimize pain if not prompted prior to therapy sessions.  Patient was discharged with Tylenol and Percocet for pain control prior to working with therapies.  Patient was stable for discharge on the morning of transfer."
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Medication error, Product storage error
Clinical narrative: Medication error. Vaccine not viable due to improper temperature storage.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Dizziness, Dyspnoea, Echocardiogram normal, Exercise tolerance decreased
Clinical narrative: On August 6, 2021, I started to experience rapid heart beat and shortness of breath. I thought I was having a heart attack and went to the ER. I was admitted to Hospital and was diagnosed the following day with POTS (Postural Orthostatic  Tachycardia Syndrome). Since then, I have been suffering daily with tachycardia, shortness of breath, lightheadedness/dizziness, heat intolerance, exercise intolerance, and light intolerance. I have not been able to return to work or resume any  normal activities.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Impaired work ability, Laboratory test normal, Loss of personal independence in daily activities, Magnetic resonance imaging normal
Clinical narrative: On August 6, 2021, I started to experience rapid heart beat and shortness of breath. I thought I was having a heart attack and went to the ER. I was admitted to Hospital and was diagnosed the following day with POTS (Postural Orthostatic  Tachycardia Syndrome). Since then, I have been suffering daily with tachycardia, shortness of breath, lightheadedness/dizziness, heat intolerance, exercise intolerance, and light intolerance. I have not been able to return to work or resume any  normal activities.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Photophobia, Postural orthostatic tachycardia syndrome, Tachycardia, Temperature intolerance
Clinical narrative: On August 6, 2021, I started to experience rapid heart beat and shortness of breath. I thought I was having a heart attack and went to the ER. I was admitted to Hospital and was diagnosed the following day with POTS (Postural Orthostatic  Tachycardia Syndrome). Since then, I have been suffering daily with tachycardia, shortness of breath, lightheadedness/dizziness, heat intolerance, exercise intolerance, and light intolerance. I have not been able to return to work or resume any  normal activities.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired on 1-15-2023
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Cough, Dyspnoea, Hypoxia
Clinical narrative: Seen at the ER for c/o SOB and cough for 1 week.  Initial Covid in ER negative.  Admitted to ward bed on 2/22/23 with Dx of pneumonia, hypoxemia, COPD to the care of the hospitalist.  On 2/23/23 patient was found unresponsive and CPR was started.  Patient was transferred to the ICU and placed on a ventilator.  Second Covid test was found to be positive.  On 2/24/23 patient was transferred to another hospital for higher level of care.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Mechanical ventilation, Pneumonia, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: Seen at the ER for c/o SOB and cough for 1 week.  Initial Covid in ER negative.  Admitted to ward bed on 2/22/23 with Dx of pneumonia, hypoxemia, COPD to the care of the hospitalist.  On 2/23/23 patient was found unresponsive and CPR was started.  Patient was transferred to the ICU and placed on a ventilator.  Second Covid test was found to be positive.  On 2/24/23 patient was transferred to another hospital for higher level of care.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Seen at the ER for c/o SOB and cough for 1 week.  Initial Covid in ER negative.  Admitted to ward bed on 2/22/23 with Dx of pneumonia, hypoxemia, COPD to the care of the hospitalist.  On 2/23/23 patient was found unresponsive and CPR was started.  Patient was transferred to the ICU and placed on a ventilator.  Second Covid test was found to be positive.  On 2/24/23 patient was transferred to another hospital for higher level of care.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Heart rate increased, Pain in extremity, Postural orthostatic tachycardia syndrome
Clinical narrative: Dizzy spells, extreme fatigue, increased heart rate, leg pain all starting about one month after vaccination. Diagnosed as Postural Orthostatic Tachycardia Syndrome (POTS) on January 19, 2023.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Biopsy bone marrow, Calcium ionised decreased, Hypercalcaemia, Laboratory test abnormal
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "80-year-old female with a past medical history of COPD, HLD, hypothyroidism, and recent hospitalization for hypercalcemia presenting again for hypercalcemia recurrence seen on outpatient labs in addition to acute metabolic encephalopathy.  Her ionized calcium was found to be 1.87. She was administered aggressive IV fluids, calcitonin, and zoledronic acid.  Patient had progressive improvement hypercalcemia with these measures. Given its recurrence, there was concern for underlying malignancy, for which the patient underwent bone marrow biopsy on 1/25/23 with Interventional Radiology. The patient tolerated the procedure well without complication. Prior to discharge, screening for COVID with rapid PCR test was positive, however the patient has been asymptomatic.  She demonstrate clinical improvement in addition to having stabilized corrected serum calcium after discontinuation of IV fluids.  She also had resolution of her presenting acute metabolic encephalopathy. She was discharged in stable condition. "
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "80-year-old female with a past medical history of COPD, HLD, hypothyroidism, and recent hospitalization for hypercalcemia presenting again for hypercalcemia recurrence seen on outpatient labs in addition to acute metabolic encephalopathy.  Her ionized calcium was found to be 1.87. She was administered aggressive IV fluids, calcitonin, and zoledronic acid.  Patient had progressive improvement hypercalcemia with these measures. Given its recurrence, there was concern for underlying malignancy, for which the patient underwent bone marrow biopsy on 1/25/23 with Interventional Radiology. The patient tolerated the procedure well without complication. Prior to discharge, screening for COVID with rapid PCR test was positive, however the patient has been asymptomatic.  She demonstrate clinical improvement in addition to having stabilized corrected serum calcium after discontinuation of IV fluids.  She also had resolution of her presenting acute metabolic encephalopathy. She was discharged in stable condition. "